Relapsed or Refractory B Cell Non-Hodgkin Lymphoma Clinical Trials in the UK

Relapsed or Refractory B Cell Non-Hodgkin Lymphoma Trials in the UK

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a UK site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full UK registry across all sponsors is far larger. UK studies may also be registered separately on ISRCTN.

Narrow the registerReset

Search within results

Recruitment status

Phase

Lead sponsor

Site city

All 3 cities

Target enrolment

Status

Study

Lead sponsor

Phase

Enrol

UK sites

Start

Recruiting

A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)

NCT06173518Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia, Relapsed or Refractory B Cell Non-Hodgkin Lymphoma

Autolus Limited

Phase 1

London, Manchester, Newcastle upon Tyne

2023-11-16

Active, closed

A Study of JNJ-90009530 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/r B-NHL)

NCT05784441Relapsed or Refractory B Cell Non-Hodgkin Lymphoma

Janssen Research & Development, LLC

Phase 1

London

2023-11-06

Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a UK investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 17 September 2026. https://priyalifescience.com/clinical-trials-uk/condition/relapsed-or-refractory-b-cell-non-hodgkin-lymphoma

Query this register directly

GET /api/trials?country=uk&status=recruiting&format=json Try it now →